Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

apamistamab-I-131 (Iomab-ACT)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Actinium

Drug class:

Beta radiation emitter, CD45 inhibitor

Related drugs:

‹

177 Lu-FC705 (0)

OTSA101-DTPA-90Y (0)

177Lu-lilotomab satetraxetan (4)

lutetium Lu 177 vipivotide tetraxetan (4)

ibritumomab tiuxetan (3)

lutetium Lu 177 dotatate (2)

177Lu-DOTA-EB-FAPI (0)

177Lu-DTPA-omburtamab (0)

177Lu-HER3 ARC (0)

177Lu-LNC1003 (0)

177Lu-LNC1004 (0)

177Lu-LNC1010 (0)

177Lu-P17-087 (0)

177Lu-P17-088 (0)

177Lu-PSMA-R2 (0)

90Y-PPMX-T002 (0)

iobenguane I 131 (0)

iodine I 131 tositumomab (0)

Cu-67 SAR-Bombesin (0)

Iodine-131-labeled metuximab (0)

epratuzumab Y-90 (0)

131I-omburtamab (0)

yttrium-90 microspheres (0)

lutetium-177 DOTA satoreotide (0)

67Cu MeCOSar octreotate (0)

177Lu-edotreotide (0)

yttrium 90 microspheres (0)

177 Lu-FC705 (0)

OTSA101-DTPA-90Y (0)

›